Market Access/ News/ News Lilly bags US okay for rival to GSK’s COVID-19 drug Xevudy Phil Taylor antibody, bebtelovimab, coronavirus, COVID-19, Eli Lilly, GlaxoSmithKline, xevudy 0 Comment Eli Lilly has been granted an emergency use authorisation from the FDA for bebtelovimab, its second COVID-19 antibody Share X Lilly bags US okay for rival to GSK’s COVID-19 drug Xevudy https://pharmaphorum.com/news/lilly-bags-us-okay-for-rival-to-gsks-covid-19-drug-xevudy/